The Anthropic IPO is shaping up to be the largest public listing in history, and investors just got their clearest look yet at the numbers behind it. Third quarter revenue hit $16.8 billion and the AI lab turned an adjusted profit for the second straight quarter. Now the only question is whether markets will pay a two trillion dollar price.
By Blumefield | October 16, 2026
A Number That Resets the Debate
For two years the loudest argument in technology has been whether artificial intelligence can ever pay for itself. The looming Anthropic IPO just delivered the most forceful answer yet. The company behind the Claude family of models posted third quarter revenue of $16.8 billion, a figure that is more than three and a half times everything it sold in all of 2025. A business that was generating roughly $1 billion in annualized recurring revenue at the start of last year is now operating at a scale most of the S&P 500 would envy.
The growth curve is almost hard to read on a normal chart. Anthropic crossed a $47 billion annualized run rate in May and a reported $65 billion by the end of July. Revenue in the second quarter grew more than 140 percent over the first, powered largely by surging demand for Claude Code, the coding tool that has quietly become one of the most used products in software development. The third quarter figure confirms that the momentum was not a one quarter fluke.
Context matters here. Only a handful of companies in history have ever scaled revenue this quickly, and none of them were spending tens of billions on the raw compute needed to train and serve frontier models. That combination, explosive top line growth alongside enormous fixed costs, is exactly what makes the coming Anthropic IPO the most closely watched financial event of the year.
Profit Changes Everything
The revenue number grabs headlines, but the detail that should reshape the conversation is profitability. Anthropic reported its second consecutive quarter of adjusted profit and said it remained cash flow positive, with an adjusted operating margin of around 11 percent for the year through the third quarter. For a company still locked in a brutal compute arms race, printing a profit this early cuts against the prevailing wisdom that frontier labs are bottomless money pits.
One metric captures the shift better than any other. In the third quarter, Anthropic says it earned about $1.70 in revenue for every dollar it spent on compute. That ratio is the clearest evidence yet that inference, the business of actually running models for paying customers, can be a genuinely good business rather than a subsidized loss leader. If that holds as usage scales, the economics of the entire sector look very different from the doom narrative that has shadowed it.
This is the heart of the bull case heading into the Anthropic IPO. Skeptics have long argued that AI companies were buying revenue with investor cash, selling tokens below cost to win market share. The figures the company has shown prospective buyers undercut that story. They describe a business that can grow and fund itself at the same time, which is precisely the profile public market investors reward with a premium.
The Two Trillion Dollar Question
That brings us to valuation, and this is where the Anthropic IPO gets genuinely contentious. Bankers advising on the deal had floated a price tag of $2 trillion or more, which would make it the largest initial public offering ever attempted. Some backers argued that even $3 trillion could be justified on a low enough multiple of projected future sales. The company was valued at a fraction of that in private rounds only months ago, a reminder of how fast expectations have moved.
In recent days that confidence has cooled. People close to the process say advisors are now weighing a valuation that could land below $1.5 trillion, a notable step down from the headline ambitions of late summer. The retreat is not a verdict on the business so much as a recognition that asking public investors to absorb a two trillion dollar debut, in a jittery market, is a very different proposition from raising money privately.
Investors reviewing the materials expect Anthropic to finish 2026 at an annualized revenue rate somewhere between $100 billion and $120 billion, and the company has reportedly projected sales approaching $190 billion to $200 billion by 2028. Whether those forward numbers justify the price will be the loudest debate on every trading desk when the shares finally list, which is now expected in November, before the Thanksgiving holiday.
Where the Cracks Are Showing
No story this large is without warning signs, and the newest data contains a few. The most obvious is deceleration. Quarter over quarter growth slowed to roughly 45 percent, a spectacular number in absolute terms but a sharp drop from the triple digit pace earlier in the year. A summer lull may explain part of it, yet the market will want to know whether the easiest gains are behind the company as its base gets larger.
A stranger risk sits in the revenue mix. Anthropic estimates that between 5 and 7 percent of its sales come from distillation, the practice of rival developers using its most capable models to train cheaper competitors. The company recently rolled out countermeasures against reasoning token theft and expects distillation revenue to fall this quarter. Losing that income strengthens the long term moat but leaves a near term dent in the very growth figures investors are scrutinizing. You can read more about the company's product strategy on the Anthropic newsroom.
Then there is the macro backdrop. The International Monetary Fund used its latest Global Financial Stability Report to warn that stretched AI valuations and circular financing arrangements between chipmakers, cloud providers and model labs could trigger a disorderly market correction. A listing of this size, arriving at this moment, becomes a referendum on exactly the concentration risk the Fund is flagging. If appetite is strong, the bulls are vindicated. If it stumbles, the warning looks prophetic.
A Verdict on the Entire AI Trade
The significance of this listing reaches far beyond one company. It is effectively a public vote on whether the trillions in AI infrastructure spending will ever generate returns that match the hype. A successful debut would hand every private AI lab, from its largest rival to the smallest startup, a credible path to the public markets and a fresh benchmark for what their own revenue is worth.
A weak reception would do the opposite. It would validate the growing chorus of analysts who believe the sector has borrowed too much against a future that has not yet arrived. Rivals racing toward their own listings will study the order book as closely as anyone, because the price investors pay here will set the ceiling for everyone else. You can follow the full market reaction and our continuing coverage at Blumefield.
For now, the company has made the strongest case it can. The revenue is real, the growth is extraordinary, and for the first time a frontier AI lab has shown it can turn a profit while still sprinting. The remaining question is one only the market can settle. When the Anthropic IPO finally prices, it will reveal whether the world is ready to put a two trillion dollar number on the promise of artificial intelligence, or whether even the best story in technology has run ahead of what buyers will pay. Investors, rivals and regulators will all be reading the same tape, and Blumefield will keep tracking the road to the Anthropic IPO and what it signals for the broader AI economy.